Head and Neck Cancer
VTX-2337 for Recurrent or Metastatic Squamous Cell Carcinomas of the Head and Neck (7406)
Phase I Clinical Trial of VTX-2337, a small molecule Toll-Like Receptor 8 (TLR8) agonist in combination with cetuximab in patients with recurrent or metastatic squamous cell carcinomas of the head and neck (SCCHN)
Investigator: Laura Chow; Conditions: Head and Neck Cancer; Status: Recruiting; Study ID: NCT01334177
A Study to Evaluate the Potential of Concomitant Ramucirumab to Affect the Pharmacokinetics of Docetaxel in Patients With Advanced Malignant Solid Tumors
Investigator: Laura Q.M. Chow, MD; Conditions: Malignant Solid Tumor; Status: Closed; Study ID: NCT01567163
A Study to Evaluate the Potential of Concomitant Ramucirumab to Affect the Pharmacokinetics of Paclitaxel in Patients With Advanced Malignant Solid Tumors
Investigator: Laura Q.M. Chow, MD; Conditions: Malignant Solid Tumor; Status: Closed; Study ID: NCT01515306
A Phase II Study of Carboplatin, Nab-paclitaxel and Cetuximab for Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Investigator: Renato G. Martins, MD, MPH; Conditions: Head and Neck Cancer; Status: Recruiting; Study ID: NCT01412229
Join Us On